Clinical Analysis on Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies in 283 Cases

张曦,陈幸华,高蕾,孔佩艳,刘红,彭贤贵,孙爱华,高力,王武,张诚,王庆余

DOI: https://doi.org/10.3969/j.issn.1671-8348.2007.17.009

2007-01-01

Abstract:Objective To evaluate the therapeutic effect of peripheral blood stem cell transplantation(PBSCT) for hematologic malignancies.Methods Two hundred and eighty-three patients with hematologic malignancies were included in PBSCT(allogenetic PBSCT in 52 patients,autologous PBSCT in 231 patients) from March 2001 to April 2007,then,the therapeutic effect and complication were oberserved,respectively.Results Hematopoieteic reconstitution was quickly obtained after autologous PBSCT in 230 patients except for one case with ALL.The incidence rate of acute GVHD was 23.1%,and chronic GVHD was 21.2%,and limited GVHD was 15.4%.Nine patients died of GVHD,infection,disease relapse or development from 1 to 16 months,and thirty-five patients were disease-free survival(DFS) from 3 to 46 months.Conclusion PBSCT is effective for the treatment of hematologic malignancies,and it is strongly suggested to select suitable mode of transplantation on account of the diagnose of disease,age and physiclal status of patient and the condition of donor.